The letter, obtained by Bloomberg Law and verified by six signatories, was sent Friday following reports that Pfizer’s clinical trial will yield conclusive results in October. That would likely put the company ahead of
But the researchers said Pfizer’s clinical trial needs to monitor participants for at least two months after they received the second dose. That would bring ...